Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-011829
Filing Date
2012-02-21
Accepted
2012-02-21 17:59:20
Documents
1
Period of Report
2012-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11861
  Complete submission text file 0001209191-12-011829.txt   13257
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Feeney John Joseph (Reporting) CIK: 0001454240 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 12628001